While the US developments were optimistic, the outcomes for impacted Australians could differ
Today, Johnson & Johnson announced its agreement to settle current ongoing US lawsuits against its talc products for US$5.5bn – however, Shine Lawyers is continuing to advance its class action against the company in Australia.
The firm filed a statement of claim on 23 July. The initial case management conference is set for 26 August.
Shine brought the suit against Johnson & Johnson and its related subsidiaries in the Supreme Court of Victoria. The suit was filed on behalf of those with biological female sex characteristics who were diagnosed with a gynaecological cancer or mesothelioma before 1 December 2025.
The class action alleges that Johnson & Johnson’s talcum powder products were defective, unfit for purpose and not of merchantable quality because they could cause cancers of the female reproductive system, of epithelial tissue or of mesothelial tissue and/or linings of the body. The claim covers the executors, administrators, beneficiaries, or trustees of the estate of such a person if they died before 1 December; moreover, it covers the dependents of an affected person, living or dead.
The class action focuses on the following products:
The Associated Press reported that in line with Johnson & Johnson’s proposed settlement, the company will issue an initial payout not exceeding US$3bn next year. The next payments are due in 2028.
The settlement is contingent on the participation of at least 95% of remaining claimants.
Craig Allsopp, head of class actions at Shine, said the firm was “encouraged” by the recent US settlements but warned Australians to “manage expectations regarding any potential compensation outcomes in Australia”.
“While developments in the United States are positive and may provide useful indicators, any compensation outcomes will depend on the specific circumstances of the Australian proceedings”, he said in a Shine Lawyers statement.
Allsopp confirmed that the firm would continue to advance the case. The current Johnson & Johnson talcum powder class action team at Shine consists of Allsopp, practice leader Sarah Thomson, and special counsels Jenny Han, Stephanie Khan and James Claridge.
